A Robotic Revolution, Step By Step

In the sometimes bi-polar world of surgical robotics, visions of a radically transformed battle with entrenched resistance to the new technology. And for now, the conservative forces have been winning. But officials at Intuitive Surgical Inc., which went public last June, argue that the tide is turning. And even some skeptics concede that Intuitive has done better than anyone thought they would just a few years ago.

In the sometimes bi-polar world of surgical robotics, visions of a radically transformed future battle with entrenched resistance to the new technology. And for now, the conservative forces have been winning. But officials at Intuitive Surgical Inc. , which went public last June [See Deal], argue that the tide is turning. And even some skeptics concede that Intuitive has done better than anyone thought they would just a few years ago.

Although its share price has bounced up and mostly down since June, Intuitive's sales and units placed have shown strong...

More from Archive

More from In Vivo

EU Medtech Outlook: The View From MedTech Europe Experts

 
• By 

MedTech Forum 2025 was less MDR-focused than in previous years, as macro issues and exogenous threats were forced further into the center of medtech business thinking.

‘Confident In Lorundrostat’s Promise’: Mineralys CEO Talks Trials And Next Steps

 

In a conversation with In Vivo, CEO Jon Congleton discusses Mineralys’s data-rich journey toward an NDA filing, the significance of recent trial wins and how its candidate may offer a dual benefit in blood pressure and renal protection.

BioBytes: Qubit Pharmaceuticals Unveils Quantum AI Model For Drug Discovery

 
• By 

Qubit Pharmaceuticals and Sorbonne University launched a quantum AI model that could slash drug synthesis requirements and enable exploration of previously undruggable targets.